Shift of conventional paradigm of heart failure treatment: from angiotensin receptor neprilysin inhibitor to sodium-glucose co-transporter 2 inhibitors?

Alexander E Berezin (First author), Alexander A Berezin

    Research output: Contribution to journalOriginal Articlepeer-review

    2 Citations (Web of Science)
    Original languageEnglish
    Pages (from-to)497-506
    JournalFUTURE CARDIOLOGY
    Volume17
    Issue number3
    DOIs
    Publication statusPublished - 2021

    Cite this